Rocuronium and Sugammadex Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome

References (1)

1. Buggenhout S, Vandenberghe J, Sienaert P. Electroconvulsion therapy for neuroleptic malignant syndrome. Tijdschr Psychiatr. 2014;56(9):612-5. 2.Arasteh M, Shami S, Nasseri K. Propofol-remifentanil combination for management of electroconvulsive therapy in a patient with neuroleptic malignant syndrome. Case Rep Med. 2012;2012:585713. 3.Tsutsumi YM, Tomiyama Y, Horikawa YT, Sakai Y, Ohshita N, Tanaka K, et al. General anesthesia for e l e c tr o c o n v u lsi v e t h e r a p y w i t h Br u g a d a electrocardiograph pattern. J Med Invest. 2011;58 (3- 4):273-6 4.Chiu CL, Jaais F, Wang CY. Effect of rocuronium compared with succinylcholine on intraocular pressure during rapid sequence induction of anaesthesia. Br J Anaesth. 1999;82 (5):757-60 5.Kadoi Y, Hoshi H, Nishida A, Saito S. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy. J Anesth. 2011;25(6):855-9